Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Microchip Technology Inc. (MCHP) vs Oscar Health Inc (OSCR) Price & Performance

Microchip Technology Inc.Trade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

Microchip Technology Inc. vs Oscar Health Inc — how do they compare? Microchip Technology Inc. trades at $80.54 (market cap $43.99B), while Oscar Health Inc trades at $29.26 (market cap $8.63B). The key difference: Microchip Technology Inc. is far larger — about 5.1× Oscar Health Inc's market cap, and Microchip Technology Inc. pays a 2.25% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.

MCHPOSCR
Market Cap
$43.99B$8.63B
Sector
TechnologyHealth
52-Week High
$102.97$32.18
52-Week Low
$49.02$10.85
Enterprise Value
$49.12B$4.99B
Dividend Yield
2.25%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Microchip Technology Inc.

Microchip Technology (MCHP) trades at $80.45, down 1.15% on the day, with a bullish technical signal and strong analyst consensus. Recent earnings beats, including Q1 2026 EPS of $0.57 versus $0.505 expected (Zacks Investment Research, 2026-08-07), highlight robust demand recovery and data center growth. The company maintains solid profitability with a 60.19% gross margin but faces high valuation multiples like a P/E of 119.15.

The outlook is positive driven by AI and data center expansion, with a consensus price target of $104.00 (MarketBeat, 2026-08-07). Risks include elevated debt levels and sensitivity to semiconductor cycles. Upside potential exists if execution continues to exceed expectations amid broadening demand.

Oscar Health Inc

Oscar Health (OSCR) trades at $29.11, up 5.2% with strong recent earnings momentum, beating estimates in Q1 and Q2 2026. The stock shows bearish technical signals but benefits from record profitability and raised 2026 guidance. Revenue surged 70% to $4.9 billion in H1 2026, with net income turning positive at $551 million versus a 2025 loss. Valuation remains attractive with P/S of 0.53, suggesting potential undervaluation versus sector peers.

Outlook is positive given membership growth and cost discipline, but risks include medical cost volatility and competitive pressures. Analyst consensus price target of $32.50 implies 12% upside, though technical resistance near $30 may limit near-term gains. Execution on guidance and sustained margin expansion are key catalysts.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Microchip Technology Inc.

Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.

Read more on MCHP

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR